↓ Skip to main content

Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis

Overview of attention for article published in Frontiers in immunology, May 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

blogs
1 blog
twitter
1 X user

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
2 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis
Published in
Frontiers in immunology, May 2023
DOI 10.3389/fimmu.2023.1162796
Pubmed ID
Authors

Alexandre Xavier, Maria Pia Campagna, Vicki E. Maltby, Trevor Kilpatrick, Bruce V. Taylor, Helmut Butzkueven, Anne-Louise Ponsonby, Rodney J. Scott, Vilija G. Jokubaitis, Rodney A. Lea, Jeannette Lechner-Scott

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 2 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 2 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 1 50%
Unknown 1 50%
Readers by discipline Count As %
Immunology and Microbiology 1 50%
Unknown 1 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 June 2023.
All research outputs
#3,860,083
of 26,173,059 outputs
Outputs from Frontiers in immunology
#4,381
of 32,855 outputs
Outputs of similar age
#69,905
of 397,714 outputs
Outputs of similar age from Frontiers in immunology
#107
of 1,350 outputs
Altmetric has tracked 26,173,059 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,855 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 397,714 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 1,350 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.